Correlated Drug Terms (0)

---

	Name (Synonyms)	Correlation

Correlated MeSH Terms (3)

---

	Name (Synonyms)	Correlation
D011014	Pneumonia NIH	0.06
D045169	Severe Acute Respiratory Syndrome NIH	0.05
D018352	Coronavirus Infections NIH	0.04

Correlated HPO Terms (1)

---

	Name (Synonyms)	Correlation
HP:0002090	Pneumonia HPO	0.06

Primary Outcomes

Description: Determine the prevalence of neurological complications in hospitalized COVID-19 patients admitted to the intensive care unit.

Measure: Prevalence of neurological complications

Time: through study completion, on an average of 3 weeks

---

Description: Examine if empiric COVID-19 therapies are associated with difference in the prevalence and outcome of severe neurological complications of COVID-19.

Measure: Prevalence and outcome of severe neurological complications

Time: through study completion, on an average of 3 weeks

---

Description: Determine the impact of neurological complications among COVID-19 patients on mortality, functional outcome, and organizational outcomes (ICU length of stay, hospital length of stay) among patients with confirmed COVID-19.

Measure: Impact of neurological complications

Time: through study completion, on an average of 3 weeks

---

Description: Analyze characteristic patterns in cerebral imaging and electroencephalography (EEG), as well as cerebrospinal fluid (CSF) of patients, in whom a lumbar puncture has been performed for clinical reasons

Measure: Characteristic patterns in cerebral imaging and electroencephalography (EEG), as well as cerebrospinal fluid (CSF)

Time: through study completion, on an average of 3 weeks

---

Description: Analyze the brain for pathological changes and histopathological findings, if the patient dies.

Measure: Brain for pathological changes and histopathological findings (if patient dies).

Time: through study completion, on an average of 3 weeks

---